JM Vose

946 total citations
13 papers, 748 citations indexed

About

JM Vose is a scholar working on Pathology and Forensic Medicine, Oncology and Immunology. According to data from OpenAlex, JM Vose has authored 13 papers receiving a total of 748 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pathology and Forensic Medicine, 8 papers in Oncology and 4 papers in Immunology. Recurrent topics in JM Vose's work include Lymphoma Diagnosis and Treatment (11 papers), Viral-associated cancers and disorders (5 papers) and T-cell and Retrovirus Studies (3 papers). JM Vose is often cited by papers focused on Lymphoma Diagnosis and Treatment (11 papers), Viral-associated cancers and disorders (5 papers) and T-cell and Retrovirus Studies (3 papers). JM Vose collaborates with scholars based in United States. JM Vose's co-authors include PJ Bierman, JO Armitage, Anne Kessinger, JR Anderson, DD Weisenburger, J Nelson, Kim Schmit-Pokorny, J Pierson, WC Chan and DD Weisenburger and has published in prestigious journals such as Blood, Stem Cells and Seminars in Oncology.

In The Last Decade

JM Vose

13 papers receiving 731 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
JM Vose United States 10 529 461 264 199 150 13 748
JR Anderson United States 8 600 1.1× 501 1.1× 181 0.7× 224 1.1× 131 0.9× 13 757
J Pierson United States 12 519 1.0× 340 0.7× 125 0.5× 242 1.2× 108 0.7× 13 651
K Blake United States 7 501 0.9× 371 0.8× 307 1.2× 267 1.3× 88 0.6× 10 853
Paul‐André Bryon France 14 509 1.0× 338 0.7× 85 0.3× 265 1.3× 150 1.0× 18 687
A Bosly France 10 494 0.9× 322 0.7× 164 0.6× 314 1.6× 128 0.9× 18 684
C. G. A. Price United Kingdom 13 849 1.6× 589 1.3× 154 0.6× 426 2.1× 121 0.8× 15 1.1k
Annette Hänel Germany 8 462 0.9× 307 0.7× 134 0.5× 229 1.2× 109 0.7× 13 639
Yiu‐Lam Kwan Australia 7 458 0.9× 438 1.0× 101 0.4× 240 1.2× 82 0.5× 15 661
C. Foussard France 12 375 0.7× 263 0.6× 132 0.5× 236 1.2× 66 0.4× 25 517
Olivier Fitoussi France 13 614 1.2× 475 1.0× 162 0.6× 217 1.1× 192 1.3× 43 870

Countries citing papers authored by JM Vose

Since Specialization
Citations

This map shows the geographic impact of JM Vose's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by JM Vose with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites JM Vose more than expected).

Fields of papers citing papers by JM Vose

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by JM Vose. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by JM Vose. The network helps show where JM Vose may publish in the future.

Co-authorship network of co-authors of JM Vose

This figure shows the co-authorship network connecting the top 25 collaborators of JM Vose. A scholar is included among the top collaborators of JM Vose based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with JM Vose. JM Vose is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Vose, JM, et al.. (2003). Establishing an institutional model for the administration of tositumomab and iodine I 131 tositumomab. Seminars in Oncology. 30(2). 39–49. 13 indexed citations
2.
Weisenburger, DD, WC Chan, JR Anderson, et al.. (1995). Prognostic value of cellular proliferation and histologic grade in follicular lymphoma. Blood. 85(12). 3671–3678. 121 indexed citations
5.
Vose, JM, PJ Bierman, JR Anderson, et al.. (1992). Progressive disease after high-dose therapy and autologous transplantation for lymphoid malignancy: clinical course and patient follow-up. Blood. 80(8). 2142–2148. 111 indexed citations
6.
Vose, JM, PJ Bierman, JR Anderson, et al.. (1992). Progressive disease after high-dose therapy and autologous transplantation for lymphoid malignancy: clinical course and patient follow-up. Blood. 80(8). 2142–2148. 113 indexed citations
7.
Vose, JM, Anne Kessinger, PJ Bierman, et al.. (1992). The use of rhIL-3 for mobilization of peripheral blood The International Journal of Cell Cloning in previously treated patients with lymphoid malignancies. Stem Cells. 10(S1). 62–64. 17 indexed citations
8.
Warkentin, PI, DD Weisenburger, JM Vose, et al.. (1992). Bone marrow transplantation for peripheral T-cell lymphoma in children and adolescents. Blood. 80(11). 2938–2942. 1 indexed citations
11.
Vose, JM, PJ Bierman, DD Weisenburger, et al.. (1990). Comparison of high-dose therapy and autologous bone marrow transplantation for T-cell and B-cell non-Hodgkin's lymphomas. Blood. 76(2). 424–431. 1 indexed citations
12.
Vose, JM, PJ Bierman, DD Weisenburger, et al.. (1990). Comparison of high-dose therapy and autologous bone marrow transplantation for T-cell and B-cell non-Hodgkin's lymphomas. Blood. 76(2). 424–431. 52 indexed citations
13.
Bierman, PJ, et al.. (1989). Autologous bone marrow transplantation in follicular non-Hodgkin's lymphoma before and after histologic transformation. Blood. 74(7). 2579–2584. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026